1. Home
  2. NRC vs HRTX Comparison

NRC vs HRTX Comparison

Compare NRC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRC
  • HRTX
  • Stock Information
  • Founded
  • NRC 1981
  • HRTX 1983
  • Country
  • NRC United States
  • HRTX United States
  • Employees
  • NRC N/A
  • HRTX N/A
  • Industry
  • NRC Biotechnology: Commercial Physical & Biological Resarch
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRC Health Care
  • HRTX Health Care
  • Exchange
  • NRC Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • NRC 354.5M
  • HRTX 276.1M
  • IPO Year
  • NRC N/A
  • HRTX 1987
  • Fundamental
  • Price
  • NRC $14.65
  • HRTX $1.35
  • Analyst Decision
  • NRC
  • HRTX Strong Buy
  • Analyst Count
  • NRC 0
  • HRTX 2
  • Target Price
  • NRC N/A
  • HRTX $4.50
  • AVG Volume (30 Days)
  • NRC 101.8K
  • HRTX 2.6M
  • Earning Date
  • NRC 10-24-2025
  • HRTX 08-08-2025
  • Dividend Yield
  • NRC 3.27%
  • HRTX N/A
  • EPS Growth
  • NRC N/A
  • HRTX N/A
  • EPS
  • NRC 0.77
  • HRTX N/A
  • Revenue
  • NRC $140,314,000.00
  • HRTX $149,694,000.00
  • Revenue This Year
  • NRC N/A
  • HRTX $10.62
  • Revenue Next Year
  • NRC N/A
  • HRTX $12.99
  • P/E Ratio
  • NRC $19.08
  • HRTX N/A
  • Revenue Growth
  • NRC N/A
  • HRTX 9.78
  • 52 Week Low
  • NRC $9.76
  • HRTX $1.04
  • 52 Week High
  • NRC $22.99
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • NRC 47.80
  • HRTX 36.48
  • Support Level
  • NRC $14.45
  • HRTX $1.33
  • Resistance Level
  • NRC $15.60
  • HRTX $1.43
  • Average True Range (ATR)
  • NRC 0.64
  • HRTX 0.07
  • MACD
  • NRC -0.03
  • HRTX 0.02
  • Stochastic Oscillator
  • NRC 17.05
  • HRTX 45.45

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: